Evidence map›Paper›PMID 40336351›Full record

ArticleScience progress

Radiomic analysis based on machine learning of multi-sequences MR to assess early treatment response in locally advanced nasopharyngeal carcinoma.

Lei Qiu, Yinjiao Fei, Yuchen Zhu, Jinling Yuan, Kexin Shi, Mengxing Wu, Gefei Jiang, Xingjian Sun, Jinyan Luo, Yurong Li and 3 more

Abstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Transrectal Biplane Ultrasound Features and Clinical Characteristics Associated With T3-T4 Staging of Rectal Cancer: A Retrospective Study.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lei QiuDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Yinjiao FeiDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Yuchen ZhuDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Jinling YuanDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Kexin ShiDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.ORCID 0009-0002-0009-461X
Mengxing WuDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Gefei JiangDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Xingjian SunDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Jinyan LuoDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Yurong LiSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Weilin XuDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Yuandong CaoDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Shu ZhouDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.ORCID 0000-0002-6864-5177

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveThe prediction of early response in locally advanced nasopharyngeal carcinoma (LA-NPC) after concurrent chemoradiotherapy (CCRT) is important for determining the need for timely consolidation therapy. We developed a radiomic analysis of multi-sequences MR based on machine learning (ML) to assess early response in LA-NPC after CCRT.MethodsThis study retrospectively enrolled 104 LA-NPC patients, randomly divided into training (70%) and test (30%) cohorts. Radiomic features were extracted from five MR sequences (T1, T1C, T2, DWI, and ADC). Feature selection was performed using Pearson's correlation coefficient and LASSO regression to reduce redundancy. ML algorithms were compared to develop models, with suboptimal sequences excluded from the multi-sequence MR fusion model. A combined model integrating the fusion and clinical model was developed using logistic regression, and its diagnostic effectiveness was evaluated using receiver operating characteristic (ROC) analysis.ResultsIn the mono-sequence MR analysis, T1 demonstrated the lowest discriminative capacity (AUC = 0.505), followed by T2 (AUC = 0.738). Consequently, we developed a fusion model incorporating ADC, DWI, and T1C features while excluding T1 and T2. In the test cohort, the combined model outperformed both the clinical (AUC = 0.852) and fusion (AUC = 0.886) models, achieving superior effectiveness (AUC = 0.900). Shapley Additive Explanations (SHAP) analysis identified lbp_GrayLevelVariance_ADC as the most influential predictive feature.ConclusionsA combined model, which merges clinical and multi-sequences MR radiomics model, showed good performance for predicting early response of LA-NPC after CCRT.

Indexed as

Machine LearningMagnetic Resonance ImagingNasopharyngeal CarcinomaNasopharyngeal NeoplasmsAdultAgedAlgorithmsChemoradiotherapyFemaleHumansMaleMiddle AgedRadiomicsRetrospective StudiesROC CurveTreatment Outcomeearly responselocally advanced nasopharyngeal carcinomamachine learningMulti-sequenceradiomicsSHAP

Identifiers

PMID40336351
PMCPMC12062700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.